Authors:
Evene, E
Brault, M
Manche, M
Sibille, M
Montay, G
Durand, DV
Citation: E. Evene et al., Bioequivalence study of two formulations (Sachet and tablet) of cefixime after single oral doses of 200mg in healthy male volunteers, CLIN DRUG I, 21(4), 2001, pp. 287-294
Authors:
Josserand, RN
Bey-Omar, F
Rollet, J
Lejeune, H
Boggio, D
Durand, DV
Durieu, I
Citation: Rn. Josserand et al., Cystic fibrosis phenotype evaluation and paternity outcome in 50 males with congenital bilateral absence of vas deferens, HUM REPR, 16(10), 2001, pp. 2093-2097
Authors:
Zenone, T
Steineur, MP
Sibille, M
Durieu, I
Durand, DV
Citation: T. Zenone et al., Myelopathy as a first manifestation of systemic lupus erythematosus: two cases and literature review, REV MED IN, 21(12), 2000, pp. 1114-1120
Authors:
Raynal, C
Durupt, S
Durieu, I
Boudray, C
Bouhour, F
Levrat, R
Durand, DV
Citation: C. Raynal et al., Sjogren's syndrome presenting as hypokalemic paralysis with distal renal tubular acidosis: a new case, PRESSE MED, 28(35), 1999, pp. 1935-1937
Authors:
Aubriet, S
Zenone, T
Kanitakis, J
Durand, DV
Citation: S. Aubriet et al., Peripheral T-cell lymphoma occurring 9 months after hemophagocytic syndrome with favorable outcome after splenectomy, REV MED IN, 20(8), 1999, pp. 718-719
Authors:
Durieu, I
Pellet, O
Simonot, L
Durupt, S
Bellon, G
Durand, DV
Minh, VAT
Citation: I. Durieu et al., Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study, J HEPATOL, 30(6), 1999, pp. 1052-1056
Authors:
Durieu, I
Durupt, S
Josserand, RN
Durand, DV
Bey-Omar, F
Citation: I. Durieu et al., Increased sweat chloride concentrations in adult patients with pancreatic insufficiency: Cystic fibrosis phenotype or lack of specificity of sweat test?, SC J GASTR, 34(12), 1999, pp. 1260-1260
Authors:
Sibille, M
Deigat, N
Durieu, I
Guillaumont, M
Morel, D
Bienvenu, J
Massignon, D
Durand, DV
Citation: M. Sibille et al., Laboratory data in healthy volunteers: reference values, reference changes, screening and laboratory adverse event limits in phase I clinical trials, EUR J CL PH, 55(1), 1999, pp. 13-19
Authors:
Zenone, T
Felman, P
Malcus, C
Durieu, I
Durand, DV
Citation: T. Zenone et al., Indolent course of a patient with hypereosinophilic syndrome associated with clonal T-cell proliferation, AM J MED, 107(5), 1999, pp. 509-511